Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of MAGLITIN 100 mg vs JANUVIA 100 mg under fasting conditions in healthy Thai volunteers
TCTR20210317008Phase 1Completed
- Sponsor
- International Bio Service
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of sitagliptin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by International Bio Service. Started Jan 2022; status: completed.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on TCTR20210317008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210317008.